Table 1.
Baseline characteristics of the 50 included patients.
| Parameters | Total n (%) |
Chemo+ (n = 33) |
Chemo− (n = 17) |
P | |
|---|---|---|---|---|---|
| Demography | Age (years) | 62 ± 9.3 | 60 | 63 | NS |
| Male gender | 34 (68) | 22 (66) | 12 (71) | NS | |
| ASA score (I/II/III) | 8 (16)/26 (52)/16 (32) | 7/15/11 | 1/11/5 | NS | |
| BMI | 28 ± 4.7 | 27 | 28 | NS | |
|
| |||||
| Comorbidities | Hypertension | 21 (42) | 14 (44) | 7 (41) | NS |
| Diabetes mellitus | 4 (8) | 3 (9) | 1 (6) | NS | |
| Smoking | 16 (32) | 11 (33) | 5 (29) | NS | |
| Hyperlipidemia | 14 (28) | 10 (30) | 4 (24) | NS | |
|
| |||||
| Liver tests | AST (IU/L) | 30.5 ± 15.2 | 29 | 33 | NS |
| ALT (IU/L) | 31.2 ± 19 | 24 | 38 | NS | |
| γ-Glutamyl transferase (IU/L) | 86 ± 97 | 82 | 90 | NS | |
| Alkaline phosphatase (IU/L) | 110 ± 47.7 | 110 | 108 | NS | |
| Prothrombin time (%) | 89.6 ± 2.6 | 90.6 | 88.4 | NS | |
| Total bilirubin (µmol/L) | 9.2 ± 5.6 | 8.4 | 10.0 | NS | |
| Platelets count (×103/mm3) | 247 ± 111 | 220 | 251 | NS | |
ASA: anesthesiologist score association.
BMI: body mass index.
NS: not significant.